Proposed Data Collection Submitted for Public Comment and Recommendations, 1495-1496 [2025-00165]
Download as PDF
<![CDATA[
Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2025–00164 Filed 1–7–25; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60–Day–25–0666; Docket No. CDC–2025–
0001]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Pathogens of High Consequence,
which assesses the incidence and
prevalence of select high consequence
pathogens of public health importance
in acute care hospitals. In addition to
the nine diseases approved for
collection, the following three
additional diseases are being added to
the form: Influenza A (H5), Marburg,
and Oropouche.
DATES: CDC must receive written
comments on or before March 10, 2025.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2025–
0001 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:50 Jan 07, 2025
Jkt 265001
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Healthcare Safety Network
(NHSN) (OMB Control No. 0920–0666,
Exp. 12/31/2027)—Revision—
Information Collection Request—
National Center for Emerging and
Zoonotic Infection Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
1495
Background and Brief Description
The Division of Healthcare Quality
Promotion (DHQP), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC) collects
data from healthcare facilities in the
National Healthcare Safety Network
(NHSN) under OMB Control Number
0920–0666. NHSN provides facilities,
health departments, states, regions, and
the nation with data necessary to
identify problem areas, measure the
progress of prevention efforts, and
ultimately eliminate healthcareassociated infections (HAIs) nationwide.
NHSN also allows healthcare facilities
to track blood safety errors and various
HAI prevention practice methods such
as healthcare personnel influenza
vaccine status and corresponding
infection control adherence rates.
Enrollment in NHSN has
continuously increased, with over
37,000 actively reporting healthcare
facilities across the U.S. Of the total
enrolled healthcare facilities, there are
over 6,000 acute care facilities. NHSN
currently has eight components, and the
collection of information is authorized
by the Public Health Service Act (42
U.S.C. 242b, 242k, and 242m (d)),
(Attachment A1–A3). Data reported
under NHSN’s Patient Safety
Component are used to determine the
magnitude of the healthcare-associated
adverse events and trends in the rates of
the events, in the distribution of
pathogens, and in the adherence to
prevention practices. Data will help
detect changes in the epidemiology of
adverse events resulting from new
medical therapies and changing patient
risks. Additionally, reported data is
being used to describe the epidemiology
of antimicrobial use and resistance and
to better understand the relationship of
antimicrobial therapy to this rising
problem.
NHSN’s data is used to aid in the
tracking of HAIs and guide infection
prevention activities/practices that
protect patients. The Centers for
Medicare and Medicaid Services (CMS)
and other payers use these data to
determine incentives for performance at
healthcare facilities across the U.S. and
surrounding territories, and members of
the public may use some protected data
to inform their selection among
available providers.Each of these parties
is dependent on the completeness and
accuracy of the data. CDC and CMS
work closely and are fully committed to
ensuring complete and accurate
reporting, which are critical for
protecting patients and guiding
E:\FR\FM\08JAN1.SGM
08JAN1
1496
Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices
national, state, and local prevention
priorities.
This Revision includes an update to
add three diseases included as part of
Form 57.130—Pathogens of High
Consequence. The original collection
captured the number of patients newly
admitted and currently hospitalized
with certain diseases in acute care
hospitals (e.g.,. Crimean-Congo
Hemorrhagic Fever (CCHF), Dengue,
Ebola, Lassa, Measles, Mpox, MERSCoV, Nipah, and Toxigenic Vibrio
cholerae) broken down by adult patients
and pediatric patients. Three additional
diseases are being added to the data
collection, Influenza A (H5), Marburg,
and Oropouche. Influenza A (H5) has
been on the CDC’s Office of Readiness
and Response website as an active
response. Marburg and Oropouche were
recently added to the website as active
responses due to international
outbreaks. It is crucial for CDC to be
aware of cases of these select infectious
diseases of public health concern to
help ensure that local and state
authorities are equipped to contain and
prevent further spread. Facilities
enrolled in the NHSN Patient Safety
Component will be asked to select the
specific diseases they are reporting on
and then provide the overall number of
patients hospitalized with confirmed
disease along with stratification of
disease in adult and pediatric patients.
The data collection will be collected
electronically via the NHSN application.
This Revision requests OMB approval
for an estimated 111,021 annual burden
hours to be added to Form 57.130—
Pathogens of High Consequence. The
total estimated annual burden hours for
the NHSN package will be increased to
4,508,255. Participation is required for
healthcare facilities that report through
the NHSN platform. There is no cost to
respondents other than their time to
participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Infection Preventionist/Microbiologist
57.130 Pathogens of High Consequence.
3,650
365
5/60
111,021
...........................................................
........................
........................
........................
4,508,255
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2025–00165 Filed 1–7–25; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–25–0469; Docket No. CDC–2024–
0105]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National
Program of Cancer Registries Cancer
Surveillance System. This information
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Number of
respondents
Type of respondents
VerDate Sep<11>2014
17:50 Jan 07, 2025
Jkt 265001
collection creates a Cancer Registry that
provides useful data on cancer
incidence, trends, and outcomes.
DATES: CDC must receive written
comments on or before March 10, 2025.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0105 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS–
D74, Atlanta, Georgia 30329; Telephone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
E:\FR\FM\08JAN1.SGM
08JAN1
]]>Agencies
[Federal Register Volume 90, Number 5 (Wednesday, January 8, 2025)]
[Notices]
[Pages 1495-1496]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00165]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-25-0666; Docket No. CDC-2025-0001]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Pathogens of High Consequence,
which assesses the incidence and prevalence of select high consequence
pathogens of public health importance in acute care hospitals. In
addition to the nine diseases approved for collection, the following
three additional diseases are being added to the form: Influenza A
(H5), Marburg, and Oropouche.
DATES: CDC must receive written comments on or before March 10, 2025.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2025-
0001 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road, NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Healthcare Safety Network (NHSN) (OMB Control No. 0920-
0666, Exp. 12/31/2027)--Revision--Information Collection Request--
National Center for Emerging and Zoonotic Infection Diseases (NCEZID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Division of Healthcare Quality Promotion (DHQP), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention (CDC) collects data from healthcare
facilities in the National Healthcare Safety Network (NHSN) under OMB
Control Number 0920-0666. NHSN provides facilities, health departments,
states, regions, and the nation with data necessary to identify problem
areas, measure the progress of prevention efforts, and ultimately
eliminate healthcare-associated infections (HAIs) nationwide. NHSN also
allows healthcare facilities to track blood safety errors and various
HAI prevention practice methods such as healthcare personnel influenza
vaccine status and corresponding infection control adherence rates.
Enrollment in NHSN has continuously increased, with over 37,000
actively reporting healthcare facilities across the U.S. Of the total
enrolled healthcare facilities, there are over 6,000 acute care
facilities. NHSN currently has eight components, and the collection of
information is authorized by the Public Health Service Act (42 U.S.C.
242b, 242k, and 242m (d)), (Attachment A1-A3). Data reported under
NHSN's Patient Safety Component are used to determine the magnitude of
the healthcare-associated adverse events and trends in the rates of the
events, in the distribution of pathogens, and in the adherence to
prevention practices. Data will help detect changes in the epidemiology
of adverse events resulting from new medical therapies and changing
patient risks. Additionally, reported data is being used to describe
the epidemiology of antimicrobial use and resistance and to better
understand the relationship of antimicrobial therapy to this rising
problem.
NHSN's data is used to aid in the tracking of HAIs and guide
infection prevention activities/practices that protect patients. The
Centers for Medicare and Medicaid Services (CMS) and other payers use
these data to determine incentives for performance at healthcare
facilities across the U.S. and surrounding territories, and members of
the public may use some protected data to inform their selection among
available providers.Each of these parties is dependent on the
completeness and accuracy of the data. CDC and CMS work closely and are
fully committed to ensuring complete and accurate reporting, which are
critical for protecting patients and guiding
[[Page 1496]]
national, state, and local prevention priorities.
This Revision includes an update to add three diseases included as
part of Form 57.130--Pathogens of High Consequence. The original
collection captured the number of patients newly admitted and currently
hospitalized with certain diseases in acute care hospitals (e.g.,.
Crimean-Congo Hemorrhagic Fever (CCHF), Dengue, Ebola, Lassa, Measles,
Mpox, MERS-CoV, Nipah, and Toxigenic Vibrio cholerae) broken down by
adult patients and pediatric patients. Three additional diseases are
being added to the data collection, Influenza A (H5), Marburg, and
Oropouche. Influenza A (H5) has been on the CDC's Office of Readiness
and Response website as an active response. Marburg and Oropouche were
recently added to the website as active responses due to international
outbreaks. It is crucial for CDC to be aware of cases of these select
infectious diseases of public health concern to help ensure that local
and state authorities are equipped to contain and prevent further
spread. Facilities enrolled in the NHSN Patient Safety Component will
be asked to select the specific diseases they are reporting on and then
provide the overall number of patients hospitalized with confirmed
disease along with stratification of disease in adult and pediatric
patients. The data collection will be collected electronically via the
NHSN application.
This Revision requests OMB approval for an estimated 111,021 annual
burden hours to be added to Form 57.130--Pathogens of High Consequence.
The total estimated annual burden hours for the NHSN package will be
increased to 4,508,255. Participation is required for healthcare
facilities that report through the NHSN platform. There is no cost to
respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Infection Preventionist/ 57.130 Pathogens 3,650 365 5/60 111,021
Microbiologist. of High
Consequence.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 4,508,255
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2025-00165 Filed 1-7-25; 8:45 am]
BILLING CODE 4163-18-P
